China Resources Medical Holdings Company Limited (1515.HK)
HKD 3.97
(-0.5%)
HKD 3.97
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.1 Billion | 5.62 Billion | 4.44 Billion | 2.75 Billion | 2.11 Billion | 2.05 Billion |
| Cost of Revenue | 8.2 Billion | 4.64 Billion | 3.51 Billion | 2.11 Billion | 1.35 Billion | 1.3 Billion |
| Gross Profit | 1.9 Billion | 971.14 Million | 933.55 Million | 636.5 Million | 762.29 Million | 756.67 Million |
| Operating Expenses | 1.05 Billion | 776.3 Million | 727.08 Million | 283.85 Million | 270.06 Million | 228.77 Million |
| Selling, General and Administrative Expenses | 1.05 Billion | 686.49 Million | 565.87 Million | 358.39 Million | 253.56 Million | 223.43 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 58.84 Million | 32.15 Million | 10.32 Million | 7.5 Million | 4.16 Million |
| Cost and Expenses | 9.25 Billion | 5.42 Billion | 4.24 Billion | 2.39 Billion | 1.62 Billion | 1.53 Billion |
| Operating Income | 852.41 Million | 284.64 Million | 367.67 Million | 278.11 Million | 508.72 Million | 533.24 Million |
| Interest Expense | 114.86 Million | 46.23 Million | 16.23 Million | 17.01 Million | 16.43 Million | 7.7 Million |
| Income Tax Expense | 165.03 Million | 83.07 Million | 155.38 Million | 97.86 Million | 140.66 Million | 149.38 Million |
| Earnings before Tax | 492.92 Million | 242.41 Million | 270.47 Million | 418.18 Million | 541.29 Million | 588.94 Million |
| Net Income | 257.68 Million | 138.97 Million | 417.91 Million | 310.13 Million | 390.86 Million | 430.89 Million |
| Earnings Per Share Basic | 0.20 | 0.11 | 0.33 | 0.25 | 0.31 | 0.34 |
| Earnings Per Share Diluted | 0.20 | 0.11 | 0.33 | 0.25 | 0.31 | 0.34 |
| Weighted Average Shares Outstanding | 1.28 Billion | 1.26 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion | 1.26 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.26 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion | 1.25 Billion | 1.26 Billion |
| Gross Margin | 0.19 | 0.17 | 0.21 | 0.23 | 0.36 | 0.37 |
| EBIT Margin | 0.12 | 0.10 | 0.12 | 0.14 | 0.27 | 0.29 |
| Profit Margin | 0.03 | 0.02 | 0.09 | 0.11 | 0.18 | 0.21 |
| EBITDA | 1.21 Billion | 965.24 Million | 527.9 Million | 372.57 Million | 566.45 Million | 602.86 Million |
| Earnings Before Tax Margin | 0.08 | 0.05 | 0.08 | 0.10 | 0.24 | 0.26 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 4.97 Billion | 4.99 Billion | 10.1 Billion | 5.11 Billion | 5.62 Billion | 4.69 Billion |
| Cost of Revenue | 3.93 Billion | 4.17 Billion | 8.2 Billion | 4.02 Billion | 4.64 Billion | 3.99 Billion |
| Gross Profit | 1.03 Billion | 816.34 Million | 1.9 Billion | 1.08 Billion | 971.14 Million | 700.35 Million |
| Operating Expenses | 473.67 Million | 595.58 Million | 943.05 Million | 464.11 Million | 776.3 Million | 597.79 Million |
| Selling, General and Administrative Expenses | 473.67 Million | 595.58 Million | - | 457.62 Million | - | 539.53 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | 59.95 Million | - | 58.84 Million | - |
| Cost and Expenses | 4.41 Billion | 4.77 Billion | 9.14 Billion | 4.48 Billion | 5.42 Billion | 4.59 Billion |
| Operating Income | 562.67 Million | 220.76 Million | 802.77 Million | 631.69 Million | 284.64 Million | 168.58 Million |
| Interest Expense | - | - | 114.86 Million | - | 46.23 Million | - |
| Income Tax Expense | 115.67 Million | 26.77 Million | 165.03 Million | 138.25 Million | 83.07 Million | 51.29 Million |
| Earnings before Tax | 627.32 Million | -132.2 Million | 492.92 Million | 625.12 Million | 242.41 Million | 108.98 Million |
| Net Income | 433.94 Million | -139.99 Million | 257.68 Million | 397.67 Million | 138.97 Million | 21.18 Million |
| Earnings Per Share Basic | 0.34 | -0.11 | - | 0.31 | - | 0.02 |
| Earnings Per Share Diluted | 0.34 | -0.11 | - | 0.31 | - | 0.02 |
| Weighted Average Shares Outstanding | 1.27 Billion | 1.26 Billion | 1.28 Billion | 1.28 Billion | 1.26 Billion | 1.26 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.26 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion |
| Gross Margin | 0.21 | 0.16 | 0.19 | 0.21 | 0.17 | 0.15 |
| EBIT Margin | 0.17 | 0.10 | - | 0.17 | - | 0.09 |
| Profit Margin | 0.09 | -0.03 | 0.03 | 0.08 | 0.02 | 0.00 |
| EBITDA | 840.13 Million | 519.05 Million | - | 892.29 Million | - | 436.92 Million |
| Earnings Before Tax Margin | 0.11 | 0.04 | 0.08 | 0.12 | 0.05 | 0.04 |
AMLX
5956
600202
TRMK
5759
AWR